B+
Bull case
20%
Probability
Target price
$230.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
NHC
National HealthCareCNYSE American / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
55%
Probability
Target price
$212.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$184.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-05
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+53.9
Score
AI commentary
Primary-source tone is constructive on Q1 earnings and the completed acquisition, but forward visibility is limited. No verified Q2 earnings release, analyst revision, target change, consensus comparison, or post-print price reaction was found in the bounded check. Social sentiment, options data, short interest, and employee-rating data were not available in the packet; the included sentiment fields should therefore be treated as unavailable rather than directional evidence.
RankAlpha Sentiment Codex - 2026-08-05
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-31eventDividend increase provides modest shareholder-return supportMedium impact
NHC announced a 4.7% increase in its regular quarterly dividend to $0.67 per share, payable July 31, 2026.
2026-11-03eventPost-earnings verification remains unresolvedMedium impact
The scheduled T+3 follow-up references a July 31 earnings date, but the bounded source check did not verify a Q2 company release, SEC earnings 8-K, analyst revisions, consensus surprise, or post-print price reaction. Treat this as a monitoring checkpoint rather than a confirmed positive catalyst.
2026-11-03eventQ1 operating momentum remains supportiveMedium impact
Q1 2026 revenue rose 2.2% year over year, while adjusted net income increased 21.1% and adjusted diluted EPS rose to $1.91 from $1.59; the results were filed with the SEC and released by the company [#PR-EARNINGS-2026-05-08] [#SEC-8K-2026-05-08].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-05 • Updated nightlySource: Internal modelMethodology